Interestingly, the amount of CD4+ T cells expressing CCR5 in SM and SF of our early OA patients is comparably high as previously described in SF of patients with different forms of rheumatic joint diseases such as RA, psoriatic arthritis, and ankylosing spondylitis [19, 20]. The gene discussed is CCR5; the disease is ankylosing spondylitis.